Healthcare & Life Sciences Industry Updates

Google News – FDA (biotech/pharma) External News

Is UroGen Pharma (URGN) Undervalued Following FDA Clearance For UGN 501? - simplywall.st

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

H.C. Wainwright reiterates UroGen Pharma stock rating on FDA clearance - Investing.com

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

Prime wins Beam arbitration, clearing path to clinic - STAT

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti - Fierce Pharma

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

Piramal Pharma shares gain over 3% as US FDA closes inspection at Sellersville facility - TradingView

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

OKYO Pharma clears key FDA milestone, advances toward Phase 3 trial for Neuropathic corneal pain - Yahoo Finance

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

Piramal Pharma Share Price Gains Over 3% As US FDA Closes Inspection - NDTV Profit

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

Piramal Pharma Sellersville Site Clears US FDA Inspection with 0 Observations Reported - Sahi

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

Piramal Pharma shares rise 4% on successful closure of US FDA inspection - Business Standard

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials - Bayer

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

First patient receives Forzinity in Mighty Therapeutics’ Phase IV study - Clinical Trials Arena

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Sparian Biosciences advances non-opioid pain drug toward clinical testing with NIDA support - AllSci

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Matica Bio Partners with VaxDome to Advance Novel Intranasal Antiviral Vaccine Platform into Clinical Trials - BioPharma APAC

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

From Potential to Practical at DIA 2026: Structure Before AI - Contract Pharma

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer - Morningstar

news.google.com · 10 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Is UroGen Pharma (URGN) Undervalued Following FDA Clearance For UGN 501? - simplywall.st

H.C. Wainwright reiterates UroGen Pharma stock rating on FDA clearance - Investing.com

Prime wins Beam arbitration, clearing path to clinic - STAT

FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti - Fierce Pharma

Piramal Pharma shares gain over 3% as US FDA closes inspection at Sellersville facility - TradingView

OKYO Pharma clears key FDA milestone, advances toward Phase 3 trial for Neuropathic corneal pain - Yahoo Finance

Piramal Pharma Share Price Gains Over 3% As US FDA Closes Inspection - NDTV Profit

Piramal Pharma Sellersville Site Clears US FDA Inspection with 0 Observations Reported - Sahi

Piramal Pharma shares rise 4% on successful closure of US FDA inspection - Business Standard

The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials - Bayer

First patient receives Forzinity in Mighty Therapeutics’ Phase IV study - Clinical Trials Arena

Sparian Biosciences advances non-opioid pain drug toward clinical testing with NIDA support - AllSci

Matica Bio Partners with VaxDome to Advance Novel Intranasal Antiviral Vaccine Platform into Clinical Trials - BioPharma APAC

From Potential to Practical at DIA 2026: Structure Before AI - Contract Pharma

Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer - Morningstar